154 related articles for article (PubMed ID: 17050596)
1. Viral infection of the lungs through the eye.
Bitko V; Musiyenko A; Barik S
J Virol; 2007 Jan; 81(2):783-90. PubMed ID: 17050596
[TBL] [Abstract][Full Text] [Related]
2. Kinetics of Respiratory Syncytial Virus (RSV) Memphis Strain 37 (M37) Infection in the Respiratory Tract of Newborn Lambs as an RSV Infection Model for Human Infants.
Larios Mora A; Detalle L; Van Geelen A; Davis MS; Stohr T; Gallup JM; Ackermann MR
PLoS One; 2015; 10(12):e0143580. PubMed ID: 26641081
[TBL] [Abstract][Full Text] [Related]
3. Activation of cytokines and NF-kappa B in corneal epithelial cells infected by respiratory syncytial virus: potential relevance in ocular inflammation and respiratory infection.
Bitko V; Garmon NE; Cao T; Estrada B; Oakes JE; Lausch RN; Barik S
BMC Microbiol; 2004 Jul; 4():28. PubMed ID: 15256003
[TBL] [Abstract][Full Text] [Related]
4. Immunostimulatory Defective Viral Genomes from Respiratory Syncytial Virus Promote a Strong Innate Antiviral Response during Infection in Mice and Humans.
Sun Y; Jain D; Koziol-White CJ; Genoyer E; Gilbert M; Tapia K; Panettieri RA; Hodinka RL; López CB
PLoS Pathog; 2015 Sep; 11(9):e1005122. PubMed ID: 26336095
[TBL] [Abstract][Full Text] [Related]
5. Effects of respiratory syncytial virus infection on dendritic cells and cysteinyl leukotrienes in lung tissues of a murine model of asthma.
Matsuse H; Hirose H; Tsuchida T; Fukahori S; Fukushima C; Mizuta Y; Kohno S
Allergol Int; 2007 Jun; 56(2):165-9. PubMed ID: 17460444
[TBL] [Abstract][Full Text] [Related]
6. Respiratory syncytial virus upregulates IL-33 expression in mouse model of virus-induced inflammation exacerbation in OVA-sensitized mice and in asthmatic subjects.
Nikonova A; Shilovskiy I; Galitskaya M; Sokolova A; Sundukova M; Dmitrieva-Posocco O; Mitin A; Komogorova V; Litvina M; Sharova N; Zhernov Y; Kudlay D; Dvornikov A; Kurbacheva O; Khaitov R; Khaitov M
Cytokine; 2021 Feb; 138():155349. PubMed ID: 33132030
[TBL] [Abstract][Full Text] [Related]
7. Effects of cannabinoid receptor type 2 in respiratory syncytial virus infection in human subjects and mice.
Tahamtan A; Samieipoor Y; Nayeri FS; Rahbarimanesh AA; Izadi A; Rashidi-Nezhad A; Tavakoli-Yaraki M; Farahmand M; Bont L; Shokri F; Mokhatri-Azad T; Salimi V
Virulence; 2018 Jan; 9(1):217-230. PubMed ID: 28992427
[TBL] [Abstract][Full Text] [Related]
8. Genetic delivery of an anti-RSV antibody to protect against pulmonary infection with RSV.
Skaricic D; Traube C; De B; Joh J; Boyer J; Crystal RG; Worgall S
Virology; 2008 Aug; 378(1):79-85. PubMed ID: 18556039
[TBL] [Abstract][Full Text] [Related]
9. A novel 5-lipoxygenase-activating protein inhibitor, AM679, reduces inflammation in the respiratory syncytial virus-infected mouse eye.
Musiyenko A; Correa L; Stock N; Hutchinson JH; Lorrain DS; Bain G; Evans JF; Barik S
Clin Vaccine Immunol; 2009 Nov; 16(11):1654-9. PubMed ID: 19759251
[TBL] [Abstract][Full Text] [Related]
10. Inducible expression of inflammatory chemokines in respiratory syncytial virus-infected mice: role of MIP-1alpha in lung pathology.
Haeberle HA; Kuziel WA; Dieterich HJ; Casola A; Gatalica Z; Garofalo RP
J Virol; 2001 Jan; 75(2):878-90. PubMed ID: 11134301
[TBL] [Abstract][Full Text] [Related]
11. Immune and functional role of nitric oxide in a mouse model of respiratory syncytial virus infection.
Stark JM; Khan AM; Chiappetta CL; Xue H; Alcorn JL; Colasurdo GN
J Infect Dis; 2005 Feb; 191(3):387-95. PubMed ID: 15633098
[TBL] [Abstract][Full Text] [Related]
12. Respiratory syncytial virus-induced airway hyperresponsiveness is independent of IL-13 compared with that induced by allergen.
Park JW; Taube C; Yang ES; Joetham A; Balhorn A; Takeda K; Miyahara N; Dakhama A; Donaldson DD; Gelfand EW
J Allergy Clin Immunol; 2003 Dec; 112(6):1078-87. PubMed ID: 14657862
[TBL] [Abstract][Full Text] [Related]
13. Characterization of recombinant respiratory syncytial viruses with the region responsible for type 2 T-cell responses and pulmonary eosinophilia deleted from the attachment (G) protein.
Elliott MB; Pryharski KS; Yu Q; Boutilier LA; Campeol N; Melville K; Laughlin TS; Gupta CK; Lerch RA; Randolph VB; LaPierre NA; Dack KM; Hancock GE
J Virol; 2004 Aug; 78(16):8446-54. PubMed ID: 15280453
[TBL] [Abstract][Full Text] [Related]
14. Effect of preexposure to ultrafine carbon black on respiratory syncytial virus infection in mice.
Lambert AL; Trasti FS; Mangum JB; Everitt JI
Toxicol Sci; 2003 Apr; 72(2):331-8. PubMed ID: 12660365
[TBL] [Abstract][Full Text] [Related]
15.
Rijsbergen LC; Rennick LJ; Laksono BM; van Run PRWA; Kuiken T; Duprex WP; de Swart RL; de Vries RD
J Gen Virol; 2020 Oct; 101(10):1037-1046. PubMed ID: 32692644
[TBL] [Abstract][Full Text] [Related]
16. Lack of effect of bovine lactoferrin in respiratory syncytial virus replication and clinical disease severity in the mouse model.
Gualdi L; Mertz S; Gomez AM; Ramilo O; Wittke A; Mejias A
Antiviral Res; 2013 Aug; 99(2):188-95. PubMed ID: 23735300
[TBL] [Abstract][Full Text] [Related]
17. Use of a highly sensitive strand-specific quantitative PCR to identify abortive replication in the mouse model of respiratory syncytial virus disease.
Bannister R; Rodrigues D; Murray EJ; Laxton C; Westby M; Bright H
Virol J; 2010 Sep; 7():250. PubMed ID: 20860795
[TBL] [Abstract][Full Text] [Related]
18. Respiratory syncytial virus-induced chemokine production: linking viral replication to chemokine production in vitro and in vivo.
Miller AL; Bowlin TL; Lukacs NW
J Infect Dis; 2004 Apr; 189(8):1419-30. PubMed ID: 15073679
[TBL] [Abstract][Full Text] [Related]
19. Respiratory syncytial virus persistence in the lungs correlates with airway hyperreactivity in the mouse model.
Estripeaut D; Torres JP; Somers CS; Tagliabue C; Khokhar S; Bhoj VG; Grube SM; Wozniakowski A; Gomez AM; Ramilo O; Jafri HS; Mejias A
J Infect Dis; 2008 Nov; 198(10):1435-43. PubMed ID: 18828742
[TBL] [Abstract][Full Text] [Related]
20. Dual proinflammatory and antiviral properties of pulmonary eosinophils in respiratory syncytial virus vaccine-enhanced disease.
Su YC; Townsend D; Herrero LJ; Zaid A; Rolph MS; Gahan ME; Nelson MA; Rudd PA; Matthaei KI; Foster PS; Dent L; Tripp RA; Lee J; Simson L; Mahalingam S
J Virol; 2015 Feb; 89(3):1564-78. PubMed ID: 25410867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
